A Randomized Clinical Trial to Assess Safety and Efficacy of Allogeneic Adipose-derived Mesenchymal Stem Cells in Promoting the Recovery of Erectile Function Post Radical Retropubic Prostatectomy of Localized Prostate Cancer
Latest Information Update: 07 Apr 2026
At a glance
- Drugs Autologous adipose derived mesenchymal stem cells Hope Biosciences (Primary)
- Indications Prostate cancer
- Focus Adverse reactions; Therapeutic Use
Most Recent Events
- 07 Apr 2026 Planned initiation date changed from 1 Jul 2025 to 10 Mar 2026.
- 10 Jul 2025 New trial record